Determine the tolerability and short-term effectiveness of hylan G-F 20 (Synvisc) in patients with symptomatic osteoarthritis (OA) of the knee in standard clinical practice

Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.

Article specifications

This clinical study was published in 2005 in Journal of Curr Med Res Opin. (IF 2005: 3.21) by German specialists. The purpose of this study was to determine the tolerability and short-term effectiveness of hylan G-F 20 (Synvisc) in patients with symptomatic osteoarthritis (OA) of the knee in standard clinical practice.

 

Result

In this population of 4253 patients treated with hylan G-F 20 for OA knee pain, the overall incidence of local, treatment-related AEs was low and consistent with those reported in the current US product labeling and previously published studies. Additionally, short-term effectiveness was confirmed.

 

Tags: Germany current medical research and opinion Clinical trial 2005

Hayland Center

© 2018 HYLAND.CENTER ALL RIGHTS RESERVED